RecruitingNCT06805682

Prospective Cohort Study of Protected Children

PEGASE3, Experimental Program of a Standardized Health Protocol Applied to Children Who Benefited From a Child Protection Measure Before the Age of Five: Effectiveness and Efficiency


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

400 participants

Start Date

Feb 18, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

A significant number of children are abused or neglected every year. This exposure is associated with short- and long-term consequences for their mental and somatic health. In France, 308,000 minors are benefiting from at least one child protective service or measure. There are few data on the health status of this population, and how it is evolving. Against this backdrop, interventions are needed to address the many needs of these children early and comprehensively, both in the short and long term. The PEGASE program, funded by the French government under Article 51, aims to ensure adequate medical follow-up - both somatic and psychiatric - for children taken into care by child protective services (CPS). An evaluation of the program's effectiveness and efficiency is needed to inform public decision-making on the appropriateness of extending it to all children under CPS's care. This requires the creation of a control cohort of children followed by CPS but not benefiting from the PEGASE program, the ESPER cohort (Prospective cohort study of protected children), which will enable us to carry out a comparative evaluation of the PEGASE program, as well as to provide information on the health of children followed by the CPS at the time of their placement and its evolution over time, data which are rare in France. The main objective is to evaluate the effectiveness of the PEGASE program on the evolution of the mental health of children followed by the CPS after 2 years of follow-up.


Eligibility

Min Age: 0 MonthsMax Age: 42 Months

Inclusion Criteria4

  • Child under the supervision of child protective services,
  • Arriving for the first time in a participating center,
  • Less than 42 months old (i.e. 3 and a half years),
  • Non-opposition of the holders of parental authority (in the event of impossibility to obtain the non-opposition of both holders of parental authority, the non-opposition of one of them will be obtained).

Exclusion Criteria1

  • • Children whose child protection measure has not been confirmed by a judicial or administrative decision.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERUsual Care

Children will be followed using each CPS participating center's usual practices


Locations(7)

Maternal and Child Protection - The Eure Department

Évreux, France, France

Departmental institution to support - accompany - educate

Lille, France, France

Moselle Departmental Children's Centre

Metz, France, France

Maternal and Child Protection

Rouen, France, France

Maternal and Child Protection

Saint-Brieuc, France, France

Children and Family Home of the Loire

Saint-Genest-Lerpt, France, France

Departmental Observatory for Child Protection

Toulon, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06805682


Related Trials